Incyte Corp (INCY)
56.95
-0.17
(-0.30%)
USD |
NASDAQ |
Mar 28, 16:00
56.97
+0.02
(+0.04%)
After-Hours: 20:00
Incyte 1 Year Total Returns (Daily): -19.00% for March 28, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
March 28, 2024 | -19.00% |
March 27, 2024 | -19.33% |
March 26, 2024 | -19.48% |
March 25, 2024 | -18.15% |
March 22, 2024 | -21.15% |
March 21, 2024 | -21.46% |
March 20, 2024 | -21.53% |
March 19, 2024 | -20.77% |
March 18, 2024 | -22.11% |
March 15, 2024 | -19.46% |
March 14, 2024 | -20.89% |
March 13, 2024 | -19.49% |
March 12, 2024 | -17.61% |
March 11, 2024 | -15.58% |
March 08, 2024 | -18.66% |
March 07, 2024 | -20.64% |
March 06, 2024 | -21.87% |
March 05, 2024 | -24.06% |
March 04, 2024 | -23.00% |
March 01, 2024 | -24.13% |
February 29, 2024 | -24.19% |
February 28, 2024 | -22.08% |
February 27, 2024 | -20.38% |
February 26, 2024 | -21.41% |
February 23, 2024 | -21.98% |
Date | Value |
---|---|
February 22, 2024 | -22.42% |
February 21, 2024 | -23.14% |
February 20, 2024 | -25.54% |
February 16, 2024 | -25.92% |
February 15, 2024 | -25.68% |
February 14, 2024 | -27.05% |
February 13, 2024 | -25.90% |
February 12, 2024 | -27.02% |
February 09, 2024 | -29.03% |
February 08, 2024 | -28.75% |
February 07, 2024 | -29.17% |
February 06, 2024 | -29.31% |
February 05, 2024 | -30.56% |
February 02, 2024 | -30.94% |
February 01, 2024 | -30.89% |
January 31, 2024 | -30.97% |
January 30, 2024 | -29.13% |
January 29, 2024 | -29.44% |
January 26, 2024 | -29.50% |
January 25, 2024 | -28.30% |
January 24, 2024 | -27.26% |
January 23, 2024 | -25.89% |
January 22, 2024 | -26.08% |
January 19, 2024 | -26.69% |
January 18, 2024 | -25.64% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-34.97%
Minimum
Dec 08 2023
56.29%
Maximum
Dec 24 2019
-0.94%
Average
-4.40%
Median
Sep 07 2022
1 Year Total Returns (Daily) Benchmarks
Novartis AG | 10.38% |
MorphoSys AG | 349.3% |
Biogen Inc | -20.21% |
Illumina Inc | -35.78% |
Johnson & Johnson | 7.39% |